Precision medicine for autoimmune patients
Precision medicine uses an individual’s genomic information, additional biomarkers, environment, and lifestyle to determine the best course of treatment for their disease.
Unlike precision medicine for cancer which primarily relies on DNA mutation testing to make decision on treatment, autoimmune disease looks at RNA, DNA’s dynamic cousin.
For lupus, Type-1 Interferon (IFN-1) expression is particularly relevant as well as biomarkers related to T- and B-Cell activity. For multiple sclerosis, B-cell markers are important.
DxTerity is bringing convenient, in-office and at-home testing tools to enable patients to take an active role in managing their health. The combination of simple sample collection and test results powered by state-of-the-art technologies provides reliable tools for providers to guide patients in their health journey.